Opportunity in crisis? India's medical device sector eyes post tariffs world
In a recent webinar hosted by ETHealthworld, industry experts examined the implications of recent US developments.
Read More
Webinar on Tariffs Trade offs Can Indian Device Makers Hold Ground Amid Global Trade Strain
At a time when the Indian medical device industry is being hailed as a sunrise sector, with domestic manufacturers eyeing the US as a key market.
Read More
US harming its own citizens by putting excessive tariffs on medical technology: MTaI
US President Donald Trump has announced reciprocal tariffs on about 60 countries to counter higher duties imposed globally on American products. Pavan Choudary, Chairman, Medical Technology Association of India (MTaI) said that the U.S. administration’s decision to impose reciprocal tariffs does not reflect informed policymaking. Source:- Financial Express
Read More
Indian medical devices industry calls USA's 27% tariff challenge for growth
Indian medical device manufacturers expect challenges for their growth in the United States (US) after President Donald Trump announced imposing a 27 per cent reciprocal tariff on imports from India. The new tariffs may impact India Source:- Business Standard
Read More
Indian Med Device makers face stiff test as US tariffs take effect, eyes diplomatic escape
Over the recent tariff announced by the US President, industry bodies in India have called the move a significant challenge to the sector's growth and stakeholders have voiced to explore bilateral routes for a balanced approach to serve mutual interest. Source:- ET Healthworld
Read More
Medtech sectors views US tariff hike as barrier to growth
US President Donald Trump announced tariffs on April 2, 2025 as part of his “Liberation Day” economic plan. The tariffs include a 26 per cent reciprocal duty on Indian imports. The Trump administration exempted pharmaceutical exports from the tariff, but medical devices were not included in the package. Source:- Express Healthcare
Read More
No tariffs on Indian pharma; plays vital role in supplying affordable medicines to US
The Trump administration has exempted the Indian pharma sector from reciprocal tariffs, recognising the vital role played by the domestic industry in supplying affordable medicines across the globe, including the US, . Source:- Zee Business
Read More
US flays India’s drug price controls
US report flags India’s price caps on stents and implants, citing inflation and innovation concerns, and says these limits affect US firms’ participation.
Read More
USTR flags hurdles for US med device exports to India before tariff move
The US Trade Representative (USTR) has flagged concerns such as delays due to the absence of guidelines for issuing import licences for refurbished devices, which are affecting medical device exports to India, in its 2025 Source:- Business Standard
Read More